LGC announces Validate ISx for Abbott and Siemens platforms

9-Mar-2022

Use of this product, the company says, assists with fulfilling various quality control requirements – such as analytical measurement range (AMR) and reportable range

LGC Maine Standards has announced the release of Validate Immunosuppressants (ISx) designed to meet the linearity and calibration verification needs of clinical laboratories running the Abbott Architect/Alinity or Siemens Dimension platforms.

The product, which includes analytes Cyclosporine (CSA)*, Tacrolimus (TAC), and Sirolimus (SIRO), is formulated in human whole blood, using the CLSI EP06-A “equal delta” sample preparation method, and provides five distinct concentrations across the range of the Abbott Architect/Alinity, or Siemens Dimension instruments. The test kits are liquid and ready-to-use; allowing users to dispense the solution from each dropper bottle directly into five sample cups, and run in replicates to verify the assay’s reportable range.

Use of this product, the company says, assists with fulfilling various quality control requirements – such as analytical measurement range (AMR) and reportable range – for linearity and calibration verification under various regulatory standards.

The company’s MSDRx data reduction software is also available at no charge for real-time data analysis, or laboratories can send data to the company directly, where a technical specialist will complete the data analysis and return a report within five business days, LGC says. Peer group comparison is also available upon request.

Sign up for your free email newsletter

IMAGE CREDIT: LCG Maine Standards

Companies